Bravnetsa is the first radioligand therapy approved through the FDA's abbreviated pathway, adding an option for adults with SSTR-positive GEP-NETs.
|Articles|November 25, 2022
Episode 34: Bladder Cancer Matters Podcast Bladder Cancer and Ostomies with Wound and Ostomy Nurse Cindy Myers
Advertisement
In Episode 34 of “Bladder Cancer Matters,” host Rick Bangs talks with Cindy Myers, RN BSN CWON. Cindy is a Certified Wound and Ostomy Nurse Specialist who has worked extensively with bladder cancer patients who undergone radical cystectomies.
Rick and Cindy discuss:
- What an ostomy is and the types of ostomies that are used by patients, especially bladder cancer patients
- The role that ostomy nurses play as patients choose their urinary diversion and prepare for surgery
- The most common questions that she gets from patients both before and after having their bladders removed
- What seems to surprise patients who receive an ileal conduit
- Sex and intimacy when having an ostomy
Rick and Cindy talk about these topics and much more in the podcast. If you would like more information about choosing a urinary diversion, you’ll want to listen to
Disclaimer: The views and opinions expressed in this podcast are those of the speakers and guests and do not necessarily reflect the views or positions of the Bladder Cancer Advocacy Network.
Advertisement
Related to this article
The investigational drug, first developed for brain cancer, is being tested to see whether it can make resistant tumors respond to treatment again.
Cancer research is increasingly looking beyond the tumor to understand the whole body, immune system and patient experience.
AI is becoming a growing part of cancer care. Learn how doctors are using it to navigate complex treatment decisions and support patients.
In patients with advanced ROS1-positive lung cancer who had not previously received a ROS1-targeted drug, Jideytro also shrank tumors that had spread to the brain in all 10 evaluable patients.
An estimated 70% of patients with stage 3 lung cancer do not see their tumors respond to standard treatment. An expert explains why, and what a new approach aims to change.
Living with stage IV kidney cancer for 10 years, one survivor shares how he manages scanxiety, uncertainty and the waiting between scans.
After facing multiple cancers and hospice care, April Floyd credits her service dog Onyx with helping her find comfort, strength and hope.
Advertisement
Advertisement
Trending on CURE
1
The Growing Role of AI in Cancer Care
2
Blood Cancer Treatments in the FDA Pipeline: What Could Come Next
3
3 More Lung Cancer Breakthroughs From WCLC 2026
4
Why Some Stage 3 Lung Cancers Don't Respond to Treatment, and What Researchers Are Trying Next
5